CNMD
CONMED Corp
NYSE · Healthcare · Medical - Devices · US
$47.68
−3.19%Year over year
Reported trailing growth
- Revenue
- +3.6%
- EBITDA
- -22.7%
- EBIT
- -13.6%
- EPS
- -48.0%
- Free cash flow
- -9.3%
- Operating cash flow
- -8.9%
Forward estimates
Based on analyst estimates
- Revenue
- +3.1%
- EBITDA
- +48.9%
- EPS
- +150.5%
Three-year CAGR
- Revenue
- +9.5%
- EBITDA
- +85.7%
- EBIT
- +26.3%
- Net income
- -14.6%
- EPS
- -14.9%
- Free cash flow
- +135.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026